Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: tktrimbath who wrote (323)	3/30/2001 2:08:16 PM
From: nigel bates	Read Replies (1) \| Respond to of 557

any guesses out there No idea. Just trying to cheer Mike up. <g> nig

To: tktrimbath who wrote (323)	3/30/2001 3:54:27 PM
From: Mark Bong	Respond to of 557

guesses? tk, this sounds modestly promising as a way to control HIV rebound when combined with the use of cocktails. In other words, the vaccine could help prolong the holiday periods when HAART users temporarily discontinue treatment by slowing down viral rebound. Timing. Check back in a year or so to see how things looked during Phase I. Don't hold your breadth.